Resistance mechanisms after tyrosine kinase inhibitors afatinib and crizotinib in non-small cell lung cancer, a review of the literature-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Resistance mechanisms after tyrosine kinase inhibitors afatinib and crizotinib in non-small cell lung cancer, a review of the literature

Published:2016-04 Issue: Volume:100 Page:107-116
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

van der -->Wekken A.J.^ORCID,Saber A.,Hiltermann T.J.N.^ORCID,Kok K.,van den -->Berg A.,Groen H.J.M.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference83 articles.

1. Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay;Arcila;Clin. Cancer Res.,2011

2. FGFR1 activation is an escape mechanism in human lung cancer cells resistant to afatinib, a pan-EGFR family kinase inhibitor;Azuma;Oncotarget,2014

3. ADAM17 regulates epidermal growth factor receptor expression through the activation of Notch1 in non-small cell lung cancer;Baumgart;Cancer Res.,2010

4. Retreatment with erlotinib: regain of TKI sensitivity following a drug holiday for patients with NSCLC who initially responded to EGFR-TKI treatment;Becker;Eur. J. Cancer,2011

5. Loi CM A phase I, open-label, mass balance study of [(14)C] dacomitinib (PF-00299804) in healthy male volunteers;Bello;Cancer Chemother. Pharmacol.,2013

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic advances of targeting receptor tyrosine kinases in cancer;Signal Transduction and Targeted Therapy;2024-08-14

2. Deciphering the Impact of Rare Missense Variants in EGFR-TKI-Resistant Non-Small-Cell Lung Cancer through Whole Exome Sequencing: A Computational Approach;ACS Omega;2024-03-25

3. Recent progress in drug delivery systems for tyrosine kinase inhibitors in the treatment of lung cancer;International Journal of Pharmaceutics;2024-01

4. Designing strategies, structural activity relationship and biological activity of recently developed nitrogen containing heterocyclic compounds as epidermal growth factor receptor tyrosinase inhibitors;Journal of Molecular Structure;2023-11

5. Sustaining the Activation of EGFR Signal by Inflammatory Cytokine IL17A Prompts Cell Proliferation and EGFR-TKI Resistance in Lung Cancer;Cancers;2023-06-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3